(Q39980300)

16 September 2017

Digital image analysis of membrane connectivity is a robust measure of HER2 immunostains (English)

1 reference

16 September 2017

0 references

8

1 reference

16 September 2017

Anja Brügmann

1

1 reference

16 September 2017

Mikkel Eld

2

1 reference

16 September 2017

Giedrius Lelkaitis

3

1 reference

16 September 2017

Søren Nielsen

4

1 reference

16 September 2017

Michael Grunkin

5

1 reference

16 September 2017

Johan D Hansen

6

1 reference

16 September 2017

Niels T Foged

7

1 reference

16 September 2017

language of work or name

English

0 references

publication date

22 April 2011

1 reference

Breast Cancer Research and Treatment

16 September 2017

1 reference

16 September 2017

132

1 reference

16 September 2017

1

1 reference

16 September 2017

41-49

1 reference

https://scigraph.springernature.com/pub.10.1007/s10549-011-1514-2

16 September 2017

0 references

cites work

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1514-2

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1514-2

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1514-2

Chromogenic in situ hybridisation (CISH) should be an accepted method in the routine diagnostic evaluation of HER2 status in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1514-2

Comparing subjective and digital image analysis HER2/neu expression scores with conventional and modified FISH scores in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1514-2

Digital image analysis improves the quality of subjective HER-2 expression scoring in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1514-2

HER-2 status in breast cancer: correlation of gene amplification by FISH with immunohistochemistry expression using advanced cellular imaging system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1514-2

HER2 amplification status in breast cancer: a comparison between immunohistochemical staining and fluorescence in situ hybridisation using manual and automated quantitative image analysis scoring techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1514-2

Evaluation of new monoclonal antibodies in detection of estrogen receptor, progesterone receptor, and Her2 protein expression in breast carcinoma cell block sections using conventional microscopy and quantitative image analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1514-2

Automated cellular imaging system III for assessing HER2 status in breast cancer specimens: development of a standardized scoring method that correlates with FISH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1514-2

Automated image analysis in histopathology: a valuable tool in medical diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1514-2

Comparison of immunohistochemistry by automated cellular imaging system (ACIS) versus fluorescence in-situ hybridization in the evaluation of HER-2/neu expression in primary breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1514-2

Image analysis as an adjunct to manual HER-2 immunohistochemical review: a diagnostic tool to standardize interpretation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1514-2

Tissue microarrays for high-throughput molecular profiling of tumor specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1514-2

Tissue microarrays: a practical guide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1514-2

The Measurement of Observer Agreement for Categorical Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1514-2

High inter-observer agreement in immunohistochemical evaluation of HER-2/neu expression in breast cancer: a multicentre GEFPICS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1514-2

Diagnostic evaluation of HER-2 as a molecular target: an assessment of accuracy and reproducibility of laboratory testing in large, prospective, randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1514-2

Predicting the HER2 status of breast cancer from basic histopathology data: an analysis of 1500 breast cancers as part of the HER2000 International Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1514-2

The invasive lobular carcinoma as a prototype luminal A breast cancer: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1514-2

Invasive lobular carcinoma with extracellular mucin production and HER-2 overexpression: a case report and further case studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1514-2

10.1007/S10549-011-1514-2

21 January 2018

Identifiers

DOI

1 reference

16 September 2017

1 reference